secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2021-11-04T23:59:59+00:00
Accession:  0001295947-21-000036
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q2 fiscal 2022 revenue record $276.2M; raises full-year guidance
-------------------------------------------------------------------------

- Record Q2 revenue $276.2M (+16.3% YoY); organic growth 10.5% ex-Akorn and FX.
- Adjusted diluted EPS $1.02, up 30.8% YoY; GAAP diluted EPS $0.89.
- Raising FY2022 outlook: revenue $1.05-$1.06B (prior $1.045B+); adj. EPS $3.93-$3.98 (prior $3.90+).
- North American OTC segment $251.7M (+16.2%); International OTC $24.5M (+17.5%).
- Adjusted free cash flow $61.9M in Q2; net debt ~$1.6B with leverage 4.1x.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594721000036/0001295947-21-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594721000036/pbh-20211104.htm
  HTML page:      https://secwatch.observer/filing/0001295947-21-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer